Veterinary Hospitals Market Segment Overview, Analysis and Forecast to 2032

FMI just issued an industry analysis study on the Veterinary Hospitals Market. According to their results, global Veterinary Hospital sales will reach roughly US$ 74.9 billion in 2022, with a 6.2% expected market growth rate between 2022 and 2032, which is much higher than the historical average.

From 2022 to 2032, private veterinary hospital applications are predicted to generate the most revenue, with a potential absolute dollar opportunity of around US$ 39.9 billion.

The growing demand for meat and milk products, as well as the growing trend of pet ownership, have fueled the growth of the Veterinary Hospitals Market. Over 98 million dogs are kept as pets in the United States alone, with pets residing in approximately 68% of American households. Furthermore, pet ownership has surged by 56% in the United States since 1988.

Pets require veterinarian care not only for emergency situations, but also for immunisations, neutering, and other treatments. This spike in pet culture has led in an increase in global demand for veterinary facilities.

Aside from the pet population, the global cow population has increased significantly in the recent decade due to increased demand for animal products worldwide. Population growth, changes in lifestyle and diet, and an increase in demand for veterinary services have all contributed to the market's expansion.

Worldwide, veterinarians have implemented additional safety precautions that have impacted their care for both sick and healthy pets, resulting in accusations of delays and extended wait periods.

Key Players:

  • CVS Group PLC
  • Greencross Vet
  • Ethos Veterinary Health
  • Pets At Home Group PLC
  • Mars Incorporated
  • Animal Hospital
  • All Pets Animal Hospital
  • Cahaba Valley Animal Clinic
  • Blaine Central Veterinary Clinic
  • Belltowne Veterinary Center

Browse Detail Summary@ https://www.futuremarketinsights.com/reports/veterinary-hospitals-market

Market Segments Covered In Veterinary Hospitals Industry Analysis

By Product Type:

  • Surgery
  • Medicine
  • Consultation

By Animal Type:

  • Companion Animals
  • Farm Animals

By Application:

  • Public
  • Private
  • Others

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more